Clinical trials
Cardiotoxicity trials
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
254 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2000 | 3 |
| 2001 | 2 |
| 2002 | 1 |
| 2006 | 4 |
| 2007 | 3 |
| 2008 | 6 |
| 2009 | 4 |
| 2010 | 6 |
| 2011 | 7 |
| 2012 | 1 |
| 2013 | 4 |
| 2014 | 12 |
| 2015 | 9 |
| 2016 | 10 |
| 2017 | 9 |
| 2018 | 10 |
| 2019 | 23 |
| 2020 | 17 |
| 2021 | 28 |
| 2022 | 20 |
| 2023 | 22 |
| 2024 | 19 |
| 2025 | 13 |
| 2026 | 16 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 90 |
| Unknown status | 64 |
| Recruiting | 44 |
| Terminated | 21 |
| Not yet recruiting | 17 |
| Active, not recruiting | 14 |
| Enrolling by invitation | 3 |
| Withdrawn | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Abramson Cancer Center at Penn Medicine | 10 |
| Children's Oncology Group | 5 |
| Groupe Hospitalier Pitie-Salpetriere | 5 |
| University College, London | 5 |
| Ain Shams University | 4 |
| Assistance Publique - Hôpitaux de Paris | 4 |
| Peking University Third Hospital | 4 |
| Washington University School of Medicine | 4 |
| AHS Cancer Control Alberta | 3 |
| Istanbul University | 3 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Cardiotoxicity | 254 |
| Breast Neoplasms | 99 |
| Heart Failure | 43 |
| Neoplasms | 43 |
| Lymphoma | 20 |
| Cardiovascular Diseases | 15 |
| Cardiomyopathies | 10 |
| Heart Diseases | 8 |
| Lung Neoplasms | 8 |
| Ventricular Dysfunction, Left | 8 |
Trials
Showing 76 to 100 of 254. Each trial links to its page on Pharma Observatory.
154 more trials match. See them on Pharma Observatory
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.